Clinical Trials Browser

Phase 2 × Leiomyosarcoma × cemiplimab × Clear all

NCT06528769 2025-09-30

Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

Phase 2 Recruiting

Leiomyosarcoma, Sarcoma